Name | (4S,5R)-5-[3,5-Bis(trifluoromethyl)phenyl]-4-methyl-1,3-oxazolidin-2-one |
---|---|
Synonyms |
(4S,5R)-5-(3,5-bis(trifluoromethyl)phenyl)-4-methyl-1,3-oxazolidin-2-one
2-Oxazolidinone, 5-[3,5-bis(trifluoromethyl)phenyl]-4-methyl-, (4S,5R)- 2-Oxazolidinone,5-[3,5-bis(trifluoromethyl)phenyl]-4-methyl-,(4S,5R) (4S,5R)-5-(3,5-bis-trifluoromethyl-phenyl)-4-methyl-oxazolidin-2-one (4S,5R)-5-[3,5-Bis(trifluoromethyl)phenyl]-4-methyl-1,3-oxazolidin-2-one (4R,5S)-5-(3,5-bis(trifluoroMethyl)phenyl)-4-Methyloxazolidin-2-one Anacetrapib Intermediate 2 |
Density | 1.4±0.1 g/cm3 |
---|---|
Boiling Point | 329.5±42.0 °C at 760 mmHg |
Molecular Formula | C12H9F6NO2 |
Molecular Weight | 313.196 |
Flash Point | 153.1±27.9 °C |
Exact Mass | 313.053741 |
PSA | 38.33000 |
LogP | 3.31 |
Vapour Pressure | 0.0±0.7 mmHg at 25°C |
Index of Refraction | 1.433 |
~98% 875444-08-9 |
Literature: MERCK and CO., INC. Patent: WO2007/81569 A2, 2007 ; Location in patent: Page/Page column 34-35 ; |
~% 875444-08-9 |
Literature: MERCK and CO., INC. Patent: WO2006/14357 A1, 2006 ; Location in patent: Page/Page column 51-52 ; |
~% 875444-08-9 |
Literature: AMIRA PHARMACEUTICALS, INC. Patent: WO2009/108720 A2, 2009 ; Location in patent: Page/Page column 132 ; WO 2009/108720 A2 |
Detail
|
Literature: MERCK and CO., INC. Patent: WO2007/81571 A2, 2007 ; Location in patent: Page/Page column 41 ; |
~% 875444-08-9 |
Literature: Ogawa, Takanori; Kumagai, Naoya; Shibasaki, Masakatsu Angewandte Chemie - International Edition, 2013 , vol. 52, # 24 p. 6196 - 6201 Angew. Chem., 2013 , vol. 125, # 24 p. 6316 - 6321 |
Precursor 5 | |
---|---|
DownStream 1 | |